Cargando…
Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
Antcins are newly identified steroid-like compounds from Taiwan’s endemic medicinal mushrooms Antrodia cinnamomea and Antrodia salmonea. Scientific studies of the past two decades confirmed that antcins have various pharmacological activities, including potent anti-oxidant and anti-inflammatory effe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399673/ https://www.ncbi.nlm.nih.gov/pubmed/34451782 http://dx.doi.org/10.3390/plants10081736 |
_version_ | 1783745134385430528 |
---|---|
author | Senthil Kumar, K. J. Gokila Vani, M. Hsieh, Han-Wen Lin, Chin-Chung Wang, Sheng-Yang |
author_facet | Senthil Kumar, K. J. Gokila Vani, M. Hsieh, Han-Wen Lin, Chin-Chung Wang, Sheng-Yang |
author_sort | Senthil Kumar, K. J. |
collection | PubMed |
description | Antcins are newly identified steroid-like compounds from Taiwan’s endemic medicinal mushrooms Antrodia cinnamomea and Antrodia salmonea. Scientific studies of the past two decades confirmed that antcins have various pharmacological activities, including potent anti-oxidant and anti-inflammatory effects. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease-2019 (COVID-19) pandemic and is characterized as a significant threat to global public health. It was recently identified that SARS-CoV-2 required angiotensin converting enzyme 2 (ACE2), a receptor which supports host cell entry and disease onset. Here, we report a novel function of antcins, in which antcins exhibit inhibitory effects on ACE2. Compared to the untreated control group, treatment with various antcins (antcin-A, antcin-B, antcin-C, antcin-H, antcin-I, and antcin-M) significantly inhibited ACE2 activity in cultured human epithelial cells. Indeed, among the investigated antcins, antcin-A, antcin-B, antcin-C, and antcin-I showed a pronounceable inhibition against ACE2. These findings suggest that antcins could be novel anti-ACE2 agents to prevent SARS-CoV-2 host cell entry and the following disease onset. |
format | Online Article Text |
id | pubmed-8399673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83996732021-08-29 Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents Senthil Kumar, K. J. Gokila Vani, M. Hsieh, Han-Wen Lin, Chin-Chung Wang, Sheng-Yang Plants (Basel) Brief Report Antcins are newly identified steroid-like compounds from Taiwan’s endemic medicinal mushrooms Antrodia cinnamomea and Antrodia salmonea. Scientific studies of the past two decades confirmed that antcins have various pharmacological activities, including potent anti-oxidant and anti-inflammatory effects. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus disease-2019 (COVID-19) pandemic and is characterized as a significant threat to global public health. It was recently identified that SARS-CoV-2 required angiotensin converting enzyme 2 (ACE2), a receptor which supports host cell entry and disease onset. Here, we report a novel function of antcins, in which antcins exhibit inhibitory effects on ACE2. Compared to the untreated control group, treatment with various antcins (antcin-A, antcin-B, antcin-C, antcin-H, antcin-I, and antcin-M) significantly inhibited ACE2 activity in cultured human epithelial cells. Indeed, among the investigated antcins, antcin-A, antcin-B, antcin-C, and antcin-I showed a pronounceable inhibition against ACE2. These findings suggest that antcins could be novel anti-ACE2 agents to prevent SARS-CoV-2 host cell entry and the following disease onset. MDPI 2021-08-23 /pmc/articles/PMC8399673/ /pubmed/34451782 http://dx.doi.org/10.3390/plants10081736 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Senthil Kumar, K. J. Gokila Vani, M. Hsieh, Han-Wen Lin, Chin-Chung Wang, Sheng-Yang Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents |
title | Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents |
title_full | Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents |
title_fullStr | Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents |
title_full_unstemmed | Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents |
title_short | Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents |
title_sort | antcins from antrodia cinnamomea and antrodia salmonea inhibit angiotensin-converting enzyme 2 (ace2) in epithelial cells: can be potential candidates for the development of sars-cov-2 prophylactic agents |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399673/ https://www.ncbi.nlm.nih.gov/pubmed/34451782 http://dx.doi.org/10.3390/plants10081736 |
work_keys_str_mv | AT senthilkumarkj antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents AT gokilavanim antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents AT hsiehhanwen antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents AT linchinchung antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents AT wangshengyang antcinsfromantrodiacinnamomeaandantrodiasalmoneainhibitangiotensinconvertingenzyme2ace2inepithelialcellscanbepotentialcandidatesforthedevelopmentofsarscov2prophylacticagents |